Cipla Partners with Stempeutics, Launches Stem Cell Therapy for Knee Osteoarthritis
Cipla has partnered with Stempeutics to launch Ciplostem, a single-dose stem cell therapy for knee osteoarthritis. The treatment uses 25 million expanded Bone Marrow–derived Mesenchymal Stem Cells (BM-MSCs) combined with hyaluronic acid to support joint repair and pain relief.
Dr Jaideep Gogtay | 04/12/2025 | By Dineshwori | 106
Cipla Launches India's First Dedicated Lung Health Diagnostics Centre in Delhi
Cipla has opened the country’s first dedicated lung diagnostics centre in Delhi, equipped to conduct over 60 tests across respiratory function, microbial studies, immune profiling, blood chemistry and imaging.
Dr Jaideep Gogtay | 29/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy